CAS No.:57-30-7

TOXICITY DATA with REFERENCE：

1.		dnr-esc 400 µg/well		ENMUDM    Environmental Mutagenesis. 3 (1981),429.
2.		msc-mus:lym 5 mmol/L		MUREAV    Mutation Research. 110 (1983),147.
3.		orl-man TDLo:36 mg/kg:CNS,GIT		BMJOAE    British Medical Journal. 1 (1955),1238.
4.		orl-rat LD50:150 mg/kg		JPETAB    Journal of Pharmacology and Experimental Therapeutics. 138 (1962),224.
5.		ipr-rat LD50:152 mg/kg		ARZNAD    Arzneimittel-Forschung. Drug Research. 33 (1983),1155.
6.		scu-rat LD50:195 mg/kg		NYKZAU    Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. 56 (1960),377.
7.		ivn-rat LD50:83 mg/kg		JMCMAR    Journal of Medicinal Chemistry. 8 (1965),220.
8.		idu-rat LDLo:100 mg/kg		ARZNAD    Arzneimittel-Forschung. Drug Research. 25 (1975),1037.
9.		orl-mus LD50:200 mg/kg		JPETAB    Journal of Pharmacology and Experimental Therapeutics. 127 (1959),318.
10.		ipr-mus LD50:123 mg/kg		JPETAB    Journal of Pharmacology and Experimental Therapeutics. 87 (1946),265.

Consensus Reports：

IARC Cancer Review: Animal Sufficient Evidence IMEMDT    IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 13 ,1977,p. 157.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) . EPA Genetic Toxicology Program.

SAFETY PROFILE：

Hazard Codes  T+
Risk Statements 25-40-43 
R25 :Toxic if swallowed. 
R40:Limited evidence of a carcinogenic effect. 
R43:May cause sensitization by skin contact.
Safety Statements 22-36/37/39-45
S22:Do not breathe dust. 
S45:In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.) 
S36/37/39:Wear suitable protective clothing, gloves and eye/face protection.
RIDADR UN 2811 6.1/PG 3
WGK Germany -
RTECS CQ7000000
HazardClass 6.1(b)
PackingGroup III
 

 

Standards and Recommendations：

 

Analytical Methods：